JOURNAL LA NOUVELLE DE SHERBROOKEBusiness Directories,Company Directories

Company Name: Corporate Name:	JOURNAL LA NOUVELLE DE SHERBROOKE
Company Title:
Company Description:
Keywords to Search:
Company Address:	1950 Rue Roy,SHERBROOKE,QC,Canada
ZIP Code: Postal Code:	J1K
Telephone Number:	8195668022
Fax Number:
Website:
Email:
USA SIC Code(Standard Industrial Classification Code):	11200
USA SIC Description:	ADVERTISING DIRECT MAIL
Number of Employees:
Sales Amount:	$1 to 2.5 million
Credit History: Credit Report:	Unknown
Contact Person:
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
JOUVENCE COIFFURE
JOURNAL VOIR
JOURNAL LA TRIBUNE

Next company profile:
JOURNAL DE SHERBROOKE
JOURNAL COMMUNAUTAIRE ENTREE
JOURNAL COMMUNAUTAIRE ENTREE LIBRE

Company News:

The New England Journal of Medicine | Research Review Articles on . . .
The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection . . .
Steroidal mineralocorticoid receptor antagonists reduce morbidity and mortality among patients with heart failure and reduced ejection fraction, but their efficacy in those with heart failure and m
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream . . .
Bloodstream infections are associated with substantial morbidity and mortality Early, appropriate antibiotic therapy is important, but the duration of treatment is uncertain In a multicenter, non
Sepsis and Septic Shock | New England Journal of Medicine
Sepsis is a life-threatening, heterogeneous disorder involving a dysregulated immune response to infection Research to identify subtypes and targeted therapies for host dysregulation is ongoing
Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis
Bacterial vaginosis affects one third of reproductive-aged women, and recurrence is common Evidence of sexual exchange of bacterial vaginosis–associated organisms between partners suggests that
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes
Zimislecel is an allogeneic stem cell–derived islet-cell therapy Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed We conducted a phase 1–2 study of
Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with . . .
Nemolizumab is a subcutaneously administered humanized monoclonal antibody against interleukin-31 receptor A, which is involved in pruritus and inflammation in atopic dermatitis In phase 2 studies
Hemophagocytic Lymphohistiocytosis | New England Journal of Medicine
HLH, a cytokine-mediated hyperinflammation syndrome, causes fever, pancytopenia, and hemophagocytosis and is often fatal Antiinflammatory agents, etoposide, and interferon-γ antibody are the
Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
In this phase 3, randomized trial conducted at 55 centers, we assigned patients with resected colon cancer who had completed adjuvant chemotherapy to participate in a structured exercise program
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
Tirzepatide and semaglutide are highly effective medications for obesity management The efficacy and safety of tirzepatide as compared with semaglutide in adults with obesity but without type 2 di